T. Rowe Price Associates’s Houlihan Lokey HLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.95M Sell
48,407
-112,418
-70% -$18.5M ﹤0.01% 1307
2025
Q4
$28M Sell
160,825
-168,623
-51% -$31M ﹤0.01% 974
2025
Q3
$67.6M Buy
329,448
+291,442
+767% +$57.1M 0.01% 704
2025
Q2
$6.84M Buy
38,006
+2,032
+6% +$341K ﹤0.01% 1202
2025
Q1
$5.81M Buy
35,974
+2,166
+6% +$372K ﹤0.01% 1223
2024
Q4
$5.87M Buy
33,808
+4,170
+14% +$734K ﹤0.01% 1250
2024
Q3
$4.68M Buy
29,638
+1,609
+6% +$240K ﹤0.01% 1319
2024
Q2
$3.78M Buy
28,029
+1,320
+5% +$173K ﹤0.01% 1307
2024
Q1
$3.42M Buy
26,709
+1,631
+7% +$202K ﹤0.01% 1339
2023
Q4
$3.01M Buy
25,078
+1,322
+6% +$143K ﹤0.01% 1370
2023
Q3
$2.54M Buy
23,756
+1,237
+5% +$128K ﹤0.01% 1372
2023
Q2
$2.21M Sell
22,519
-2,121
-9% -$192K ﹤0.01% 1437
2023
Q1
$2.16M Buy
24,640
+935
+4% +$88K ﹤0.01% 1438
2022
Q4
$2.07M Buy
23,705
+1,159
+5% +$104K ﹤0.01% 1447
2022
Q3
$1.7M Sell
22,546
-1,357,648
-98% -$110M ﹤0.01% 1519
2022
Q2
$109M Sell
1,380,194
-18,223
-1% -$1.52M 0.01% 633
2022
Q1
$123M Buy
1,398,417
+2,059
+0.1% +$212K 0.01% 664
2021
Q4
$145M Sell
1,396,358
-27,750
-2% -$2.96M 0.01% 651
2021
Q3
$131M Sell
1,424,108
-4,809
-0.3% -$421K 0.01% 683
2021
Q2
$117M Buy
1,428,917
+875
+0.1% +$63.3K 0.01% 726
2021
Q1
$95M Buy
1,428,042
+2,181
+0.2% +$147K 0.01% 797
2020
Q4
$95.9M Sell
1,425,861
-45,400
-3% -$2.94M 0.01% 741
2020
Q3
$86.9M Sell
1,471,261
-5,338
-0.4% -$306K 0.01% 700
2020
Q2
$82.2M Sell
1,476,599
-25,168
-2% -$1.47M 0.01% 692
2020
Q1
$78.3M Sell
1,501,767
-9,575
-0.6% -$496K 0.01% 646
2019
Q4
$73.9M Buy
1,511,342
+10,528
+0.7% +$497K 0.01% 769
2019
Q3
$67.7M Buy
1,500,814
+266,282
+22% +$11.8M 0.01% 754
2019
Q2
$55M Buy
1,234,532
+22,322
+2% +$1.04M 0.01% 851
2019
Q1
$55.6M Buy
1,212,210
+50,384
+4% +$2.22M 0.01% 831
2018
Q4
$42.8M Sell
1,161,826
-36,286
-3% -$1.48M 0.01% 882
2018
Q3
$53.8M Sell
1,198,112
-22,062
-2% -$1.07M 0.01% 892
2018
Q2
$62.5M Buy
1,220,174
+10,303
+0.9% +$493K 0.01% 804
2018
Q1
$54M Sell
1,209,871
-8,341
-0.7% -$395K 0.01% 841
2017
Q4
$55.3M Sell
1,218,212
-36,600
-3% -$1.57M 0.01% 831
2017
Q3
$49.1M Buy
1,254,812
+5,604
+0.4% +$205K 0.01% 855
2017
Q2
$43.6M Buy
1,249,208
+10,724
+0.9% +$364K 0.01% 873
2017
Q1
$42.7M Buy
1,238,484
+368,809
+42% +$11.8M 0.01% 862
2016
Q4
$27.1M Sell
869,675
-408,105
-32% -$11.1M 0.01% 1027
2016
Q3
$32M Buy
1,277,780
+23,540
+2% +$567K 0.01% 960
2016
Q2
$28.1M Buy
1,254,240
+152,550
+14% +$3.67M 0.01% 982
2016
Q1
$27.4M Buy
1,101,690
+217,260
+25% +$5.28M 0.01% 978
2015
Q4
$23.2M Sell
884,430
-14,850
-2% -$339K ﹤0.01% 1039
2015
Q3
$19.6M Buy
+899,280
New +$19.7M ﹤0.01% 1097

Other funds holding HLI

T. Rowe Price Associates's HLI Position: Q1 2026 in Review

T. Rowe Price Associates reduced its Houlihan Lokey (HLI) stake by 70% in Q1 2026, selling an estimated $18.5M and leaving 48,407 shares worth $6.95M. The position accounts for ﹤0.01% of the portfolio, ranked #1307.

T. Rowe Price Associates first reported a position in HLI in Q3 2015 and has held it in 43 quarters since. The position peaked at $145M in Q4 2021. 544 funds tracked by Wall St. Rank hold HLI as of Q1 2026.

  • T. Rowe Price Associates held 48,407 shares of Houlihan Lokey worth $6.95M as of Q1 2026.
  • T. Rowe Price Associates sold 112,418 Houlihan Lokey shares in Q1 2026, an estimated $18.5M.
  • Houlihan Lokey made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1307 holding.
  • T. Rowe Price Associates first reported a position in Houlihan Lokey in Q3 2015 and has held it in 43 quarters since.
  • T. Rowe Price Associates's Houlihan Lokey position peaked at $145M in Q4 2021.
  • 544 funds tracked by Wall St. Rank held Houlihan Lokey as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.